What is the current valuation of the South Korea Nanomedicine Market?

As of 2024, the South Korea Nanomedicine Market was valued at 8.21 USD Billion. Read More

What is the projected market size for the South Korea Nanomedicine Market by 2035?

The market is projected to reach approximately 29.95 USD Billion by 2035. Read More

What is the expected CAGR for the South Korea Nanomedicine Market during the forecast period?

The expected CAGR for the South Korea Nanomedicine Market from 2025 to 2035 is 12.48%. Read More

Which companies are the key players in the South Korea Nanomedicine Market?

Key players include Samsung Biologics, LG Chem, Hanmi Pharmaceutical, SK Biopharmaceuticals, and Celltrion. Read More

What are the main applications of nanomedicine in South Korea?

Main applications include Drug Delivery, Diagnostics, Therapeutics, Imaging, and Regenerative Medicine. Read More

How does the Drug Delivery segment perform in the South Korea Nanomedicine Market?

The Drug Delivery segment was valued at 2.0 USD Billion in 2024 and is projected to grow to 7.5 USD Billion by 2035. Read More

What is the market size for the Therapeutics segment in 2024?

In 2024, the Therapeutics segment was valued at 2.5 USD Billion. Read More

What is the projected growth for the Biotechnology end-use segment?

The Biotechnology end-use segment is expected to grow from 1.64 USD Billion in 2024 to 6.12 USD Billion by 2035. Read More

Which material types are significant in the South Korea Nanomedicine Market?

Significant material types include Nanoparticles, Nanotubes, Nanoplates, Nanofibers, and Nanocomposites. Read More

What technological advancements are influencing the South Korea Nanomedicine Market?

Technological advancements such as Nanolithography, Nanoprinting, and Nanoscale Fabrication are influencing market growth. Read More

South Korea Nanomedicine Market

PREVIEWTEMPLATEONLY(NOTFORPRODUCTIONUSE) SouthKoreaNanomedicineMarketResearchReport:ByApplication(DrugDelivery,DiagnosticImaging,TherapeuticApplications,RegenerativeMedicine),ByType(Nanoparticles,Nanoshells,Nanorobots,Nanocapsules),ByEndUse(Pharmaceuticals,Biotechnology,Healthcare,ResearchLaboratories)and ByTechnology(TargetedDrugDelivery,Nanocarriers,Nanotherapeutics,Nanodiagnostics) -Forecastto2035

Forecast Period

2025 - 2035

CAGR

12.48%

2018 Market Size

$ 1.38 Billion

2035 Market Size

$ 29.95 Billion

Healthcare ● Updated February 2026 Report ID: MRFR/HC/51703-HCR | Pages: 200 | Author: Vikita Thakur

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 South Korea Nanomedicine Market, BY Application (USD Billion)
  1. 4.1.1 Drug Delivery
  2. 4.1.2 Diagnostics
  3. 4.1.3 Therapeutics
  4. 4.1.4 Imaging
  5. 4.1.5 Regenerative Medicine
2. 4.2 South Korea Nanomedicine Market, BY End Use (USD Billion)
  1. 4.2.1 Pharmaceuticals
  2. 4.2.2 Biotechnology
  3. 4.2.3 Research Institutions
  4. 4.2.4 Hospitals
  5. 4.2.5 Academic Institutions
3. 4.3 South Korea Nanomedicine Market, BY Material Type (USD Billion)
  1. 4.3.1 Nanoparticles
  2. 4.3.2 Nanotubes
  3. 4.3.3 Nanoplates
  4. 4.3.4 Nanofibers
  5. 4.3.5 Nanocomposites
4. 4.4 South Korea Nanomedicine Market, BY Technology (USD Billion)
  1. 4.4.1 Nanolithography
  2. 4.4.2 Nanoprinting
  3. 4.4.3 Nanoscale Fabrication
  4. 4.4.4 Nanostructuring
  5. 4.4.5 Nanomaterials Synthesis
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the South Korea Nanomedicine Market
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the South Korea Nanomedicine Market
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Samsung Biologics (KR)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 LG Chem (KR)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Hanmi Pharmaceutical (KR)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 SK Biopharmaceuticals (KR)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Celltrion (KR)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Daewoong Pharmaceutical (KR)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Korea United Pharm (KR)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Medytox (KR)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Genexine (KR)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
3. 6.3 SOUTH KOREA MARKET ANALYSIS BY END USE
4. 6.4 SOUTH KOREA MARKET ANALYSIS BY MATERIAL TYPE
5. 6.5 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
6. 6.6 KEY BUYING CRITERIA OF SOUTH KOREA NANOMEDICINE MARKET
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF SOUTH KOREA NANOMEDICINE MARKET
9. 6.9 DRIVERS IMPACT ANALYSIS: SOUTH KOREA NANOMEDICINE MARKET
10. 6.10 RESTRAINTS IMPACT ANALYSIS: SOUTH KOREA NANOMEDICINE MARKET
11. 6.11 SUPPLY / VALUE CHAIN: SOUTH KOREA NANOMEDICINE MARKET
12. 6.12 SOUTH KOREA NANOMEDICINE MARKET, BY APPLICATION, 2024 (% SHARE)
13. 6.13 SOUTH KOREA NANOMEDICINE MARKET, BY APPLICATION, 2024 TO 2035 (USD Billion)
14. 6.14 SOUTH KOREA NANOMEDICINE MARKET, BY END USE, 2024 (% SHARE)
15. 6.15 SOUTH KOREA NANOMEDICINE MARKET, BY END USE, 2024 TO 2035 (USD Billion)
16. 6.16 SOUTH KOREA NANOMEDICINE MARKET, BY MATERIAL TYPE, 2024 (% SHARE)
17. 6.17 SOUTH KOREA NANOMEDICINE MARKET, BY MATERIAL TYPE, 2024 TO 2035 (USD Billion)
18. 6.18 SOUTH KOREA NANOMEDICINE MARKET, BY TECHNOLOGY, 2024 (% SHARE)
19. 6.19 SOUTH KOREA NANOMEDICINE MARKET, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
  2. 7.2.2 BY END USE, 2026-2035 (USD Billion)
  3. 7.2.3 BY MATERIAL TYPE, 2026-2035 (USD Billion)
  4. 7.2.4 BY TECHNOLOGY, 2026-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South Korea Nanomedicine Market Segmentation

South Korea Nanomedicine Market By Application (USD Billion, 2022-2035)

Drug Delivery
Diagnostics
Therapeutics
Imaging
Regenerative Medicine

South Korea Nanomedicine Market By End Use (USD Billion, 2022-2035)

South Korea Nanomedicine Markets
Biotechnology
Research Institutions
Hospitals
Academic Institutions

South Korea Nanomedicine Market By Material Type (USD Billion, 2022-2035)

Nanoparticles
Nanotubes
Nanoplates
Nanofibers
Nanocomposites

South Korea Nanomedicine Market By Technology (USD Billion, 2022-2035)

Nanolithography
Nanoprinting
Nanoscale Fabrication
Nanostructuring
Nanomaterials Synthesis

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”